CDH International is a registered charity in the US, UK, Netherlands, Hong Kong, Singapore, Canada and Switzerland.

Donate Now

Research: Response to: EHD-D-21-00009 – N-terminal pro-B-type natriuretic peptide, pulmonary hypertension and cardiac dysfunction in patients with congenital diaphragmatic hernia

March 15, 2021March 15, 20211 min read

Early Hum Dev

. 2021 Feb 11;155:105333. doi: 10.1016/j.earlhumdev.2021.105333. Online ahead of print. https://pubmed.ncbi.nlm.nih.gov/33689980/

Response to: EHD-D-21-00009 – N-terminal pro-B-type natriuretic peptide, pulmonary hypertension and cardiac dysfunction in patients with congenital diaphragmatic hernia

Florian Kipfmueller¹Affiliations expand

PMID: 33689980
DOI: 10.1016/j.earlhumdev.2021.105333

Full text linksCiteAbstractPubMedPMIDNo abstract available

Fundraisers for the week of December 21, 2020

Research: Postnatal care setting and survival after fetoscopic tracheal occlusion for severe congenital diaphragmatic hernia: A systematic review and meta-analysis

RESEARCH: “Prenatal treatment with rosiglitazone attenuates vascular remodeling and pulmonary monocyte influx in experimental congenital diaphragmatic hernia.”

Dean Cain on the 2019 CDH Telethon

Founded in 1995 as CHERUBS, CDH International is a global non-profit working to help over 6500 patient families in 74 countries through support services, raising awareness and funding and conducting CDH research

CDHi is a registered non-profit in the United States, Canada, United Kingdom, Switzerland, Hong Kong, Singapore and the Netherlands.

Donate Now

Translate »

Research: Response to: EHD-D-21-00009 – N-terminal pro-B-type natriuretic peptide, pulmonary hypertension and cardiac dysfunction in patients with congenital diaphragmatic hernia

Response to: EHD-D-21-00009 – N-terminal pro-B-type natriuretic peptide, pulmonary hypertension and cardiac dysfunction in patients with congenital diaphragmatic hernia

Research: [Therapy and Outcome of Neonates with Congenital Diaphragmatic Hernia and Congenital Heart Defects]

Research: Benchmarking utilization, length of stay, and complications following minimally invasive repair of major congenital anomalies

Recommended Articles

Fundraisers for the week of December 21, 2020

Research: Postnatal care setting and survival after fetoscopic tracheal occlusion for severe congenital diaphragmatic hernia: A systematic review and meta-analysis

RESEARCH: “Prenatal treatment with rosiglitazone attenuates vascular remodeling and pulmonary monocyte influx in experimental congenital diaphragmatic hernia.”

Dean Cain on the 2019 CDH Telethon